(Q28584176)

English

Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha

scientific journal article

In more languages

Statements

scholarly article

1 reference

PubMed publication ID

31 January 2017

Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha (English)

1 reference

PubMed publication ID

31 January 2017

1 reference

based on heuristic

inferred from title

author name string

Xian-sheng Huang

1

1 reference

PubMed publication ID

31 January 2017

Shui-ping Zhao

2

1 reference

PubMed publication ID

31 January 2017

Lin Bai

3

1 reference

PubMed publication ID

31 January 2017

Min Hu

4

1 reference

PubMed publication ID

31 January 2017

Wang Zhao

5

1 reference

PubMed publication ID

31 January 2017

Qian Zhang

6

1 reference

PubMed publication ID

31 January 2017

language of work or name

0 references

publication date

1 October 2009

1 reference

PubMed publication ID

31 January 2017

British Journal of Pharmacology

1 reference

PubMed publication ID

31 January 2017

158

1 reference

PubMed publication ID

31 January 2017

3

1 reference

PubMed publication ID

31 January 2017

706–712

1 reference

PubMed publication ID

31 January 2017

Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

New lipid-lowering agents acting on LDL receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

29 September 2017

Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

29 September 2017

Plasma triglyceride level and mortality from coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Peroxisome Proliferator-Activated Receptors Mediate Pleiotropic Actions of Statins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/19694729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19694729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1476-5381.2009.00350.X

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28584176&oldid=1403932820"